Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol
letter
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This case report describes livedoid vasculitis associated with anticardiolipin antibodies that showed improvement with danazol treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Journal Article Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol Get access S.H. Wakelin, S.H. Wakelin St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K., Search for other works by this author on: Oxford Academic Google Scholar J.P. Ellis, J.P. Ellis Princess Margaret Hospital, Swindon, SN1 4JU, U.K. Search for other works by this author on: Oxford Academic Google Scholar M.M. Black M.M. Black St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K., Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 139, Issue 5, 1 November 1998, Pages 935–937, https://doi.org/10.1046/j.1365-2133.1998.02541.x Published: 01 November 1998
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
References (7)
- Low-Dose Danazol in the Treatment of Livedoid Vasculitis via openalex
- doi:10.1016/s0190-9622(88)70009-2 via openalex
- doi:10.1016/s0190-9622(97)70274-3 via openalex
- doi:10.1001/archderm.96.5.489 via openalex
- doi:10.1111/j.1365-2230.1992.tb02522.x via openalex
- doi:10.1016/s0190-9622(97)80283-6 via openalex
- doi:10.1111/j.1365-2133.1989.tb04172.x via openalex
Cited by (1)
Source provenance
- crossref
- last seen: 2026-06-17T06:32:04.791310+00:00
- openalex
- last seen: 2026-05-10T10:29:58.231670+00:00
- unpaywall
- last seen: 2026-07-01T06:31:07.846910+00:00
License: CC0
· commercial use OK